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Whole-body magnetic resonance imaging for staging and
follow-up of pediatric patients with Hodgkin’s lymphoma:
comparison of different sequences*
Aplicação da ressonância magnética de corpo inteiro para o estadiamento e acompanhamento de pacientes
com linfoma de Hodgkin na faixa etária infanto-juvenil: comparação entre diferentes sequências
Daniel Nava1, Heverton Cesar de Oliveira2, Flavio Augusto Luisi3, Andrea Regina da Silveira
Ximenes4, Henrique Manoel Lederman5
Objective: To compare the performance of the T1, T2, STIR and DWIBS (diffusion-weighted whole-body imaging with
background body signal suppression) sequences in the staging and follow-up of pediatric patients with Hodgkin’s
lymphoma in lymph node chains, parenchymal organs and bone marrow, and to evaluate interobserver agreement.
Materials and Methods: The authors studied 12 patients with confirmed diagnosis of Hodgkin’s lymphoma. The patients
were referred for whole body magnetic resonance imaging with T1-weighted, T2-weighted, STIR and DWIBS sequences.
Results: The number of lymph node sites characterized as affected by the disease on T1- and T2-weighted sequences
showed similar results (8 sites for both sequences), but lower than DWIBS and STIR sequences (11 and 12 sites,
respectively). The bone marrow involvement by lymphoma showed the same values for the T1-, T2-weighted and DWIBS
sequences (17 lesions), higher than the value found on STIR (13 lesions). A high rate of interobserver agreement was
observed as the four sequences were analyzed. Conclusion: STIR and DWIBS sequences detected the highest number
of lymph node sites characterized as affected by the disease. Similar results were demonstrated by all the sequences
in the evaluation of parenchymal organs and bone marrow. A high interobserver agreement was observed as the four
sequences were analyzed.
Keywords: Whole-body magnetic resonance imaging; Diffusion; Lymphoma; DWIBS.
Objetivo: Comparar o desempenho das sequências T1, T2, STIR e DWIBS (difusão de corpo inteiro com supressão do
sinal de fundo) na identificação de sítios caracterizados como acometidos pelo linfoma de Hodgkin nas cadeias linfo-
nodais, órgãos parenquimatosos e medula óssea, e avaliar a concordância entre os examinadores. Materiais e Mé-
todos: Foram estudados 12 pacientes com diagnóstico confirmado de linfoma de Hodgkin. Os pacientes foram enca-
minhados para o exame de ressonância magnética, sendo realizadas as sequências ponderadas em T1, T2, STIR e
DWIBS. Resultados: O número de sítios linfonodais caracterizados como acometidos nas sequências ponderadas em
T1 e T2 apresentaram resultados semelhantes (8 sítios), mas inferiores às sequências STIR e DWIBS (11 e 12 sítios,
respectivamente). Quanto ao acometimento da medula óssea, observaram-se os mesmos valores para as sequências
T1, T2 e DWIBS (17 lesões), superiores ao valor encontrado na sequência STIR (13 lesões). Quando realizada a com-
paração entre os examinadores, nota-se que há alta concordância entre as quatro sequências. Conclusão: As sequên-
cias STIR e DWIBS detectaram maior número de linfonodos caracterizados como acometidos. Todas as sequências
apresentaram resultados semelhantes na avaliação dos órgãos parenquimatosos e medula óssea. Em todas as sequên-
cias analisadas houve alta concordância entre os examinadores.
Unitermos: Ressonância magnética de corpo inteiro; Difusão; Linfoma; DWIBS.
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INTRODUCTION
Lymphoma is the third most common
malignant neoplasia in the childhood, af-
ter leukemia and central nervous system tu-
mors. According to the mean gross rates
observed in the records of cancer in the
Brazilian population, the number of new
cases of Hodgkin’s lymphoma in Brazil, in
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2009, achieved approximately 1,600 in
men and 1,270 in women(1).
The evaluation of the disease extent
(staging) is important for an appropriate
treatment planning and for determining
the prognosis. Imaging methods play an es-
sential role in the staging of lymphomas.
Additionally, images are of great relevance
in the monitoring of the response to thera-
py and in the detection of tumor recur-
rence(2–6).
Whole-body imaging in children is gen-
erally performed by scanning the entire
skeleton, scintigraphy and positron emis-
sion tomography (PET), this latter being
combined with computed tomography
(CT). Exposure to ionizing radiation is a
common characteristic in all these imaging
methods, posing a negative effect that is
more significant to children than to adults.
Thus, alternative methods free of ionizing
radiations are extremely important in pedi-
atric radiology(7).
Over the past few years, there has been
an increase in the application of whole-
body magnetic resonance imaging (MRI) in
adults, particularly in oncologic radiology.
Such increase has been favored by the com-
bination of fast sequences with the exami-
nation table motion and use of a body coil,
or a specially designed platform with mul-
tiple coils.
In pediatrics, the main indication of
such method has been the detection of bone
marrow lesions(5,8), but the potential to ex-
tend this application to other systemic dis-
eases is increasing.
Diffusion-weighted MRI provides func-
tional data that may be utilized in the de-
tection and characterization of pathologi-
cal processes, malignant tumors inclu-
sive(9–12). Therefore, such method may be
valuable in the staging and follow-up of
malignant tumors. In spite of the above
mentioned developments in diffusion-
weighted imaging, apnea was previously
considered as necessary because respira-
tory motion impaired diffusion imag-
ing(13–17). In 2004, Takahara et al.(18) de-
scribed the concept of diffusion-weighted
whole-body imaging with background
body signal suppression (DWIBS). Such
technique makes intentional use of free
breathing instead of apnea, for the visual-
ization of visceral organs and their lesions.
In a later study published by Ballon et
al.(19), DWIBS was also described with free
breathing. Such study approached the visu-
alization of metastatic lesions in static tis-
sues (bone marrow), which was in agree-
ment with the theory accepted at that time.
However, those authors observed that vis-
ceral organs such as the spleen and the kid-
neys could also be analyzed.
Considering the hypothesis that differ-
ences in histologic cytoarchitecture is bet-
ter reflected by the difference of free pas-
sage of water molecules, diffusion-weighted
MRI must be the most sensitive method in
the staging of metastases, with the advan-
tage of being faster and capable of evalu-
ating larger volumes than the other se-
quences(12).
A recent study reported that diffusion-
weighted MRI is highly sensitive in the
detection of malignant diseases. For that
reason, diffusion-weighted whole-body
imaging has been proposed as a powerful
screening tool(11).
MATERIALS AND METHODS
In the period between March and No-
vember/2009, the authors developed a pro-
spective study approaching the staging of
Hodgkin’s lymphoma in 12 outpatients by
means of whole-body MRI. The protocol
was approved by the Committee for Ethics
in Research of the institution, and a term
of free and informed consent was signed by
patients and their caregivers, after a verbal
explanation on the document and the pro-
cedure. The results obtained in the present
study did not affect the clinical approach
to the patients included in the sample.
Patients with confirmed diagnosis of
early-stage Hodgkin’s lymphoma or with
clinical suspicion of recurrence were in-
cluded. Patients whose diagnosis was not
confirmed or those who did not present ap-
propriate clinical conditions to undergo the
examination were excluded.
The sample included seven male and
five female patients aged between 12 and
24 years (mean age of 17.75 years). Among
the 12 patients, six represented new cases
and 6 presented suspicion of disease recur-
rence.
The studies were performed in an
Achieva MRI equipment (Philips Medical
Systems; Cleveland, OH, USA), with a
body coil for signals transmission and re-
ception. The patients were positioned in
dorsal decubitus with the arms parallel to
the body and the sequences were acquired
with free-breathing. The utilization of in-
travenous paramagnetic contrast injection
was not necessary and none of the patients
required sedation. Based on the sagittal and
coronal images, the acquisition volume
was planned in four sections covering the
entire body, with T1-weighted sequences
(repetition time [TR] = 465 ms; echo time
[TE] = 17 ms; field-of-view [FOV] = 515
mm; matrix = 512 × 512); T2-weighted
sequences (TR = 1842 ms; TE = 80 ms;
FOV = 515 mm; matrix = 512 × 512);
STIR sequences (TR = 5420 ms; TE = 66
ms; FOV = 515 mm; matrix = 512 × 512)
and DWIBS (TR = 6348 ms; TE = 70 ms;
FOV = 515 mm; matrix = 336 × 336).
Coronal T1-weighted, T2-weighted and
STIR sequences were acquired with 7.0
mm slice thickness, and the DWIBS se-
quence was acquires in the cross-sectional,
with 5.0 mm thick slices. The T1-weighted,
T2-weighted and STIR sequences were re-
constructed by means of the Mobiview
technique, obtaining the fusion of the sec-
tions in the coronal plane, and the sequence
DWIBS was reconstructed by means of the
MIP and Mobiview techniques, also ob-
taining the fusion of sections in the coro-
nal plane.
The interpretation of the images was
made on workstations by two independent
observers, both of them with experience in
MRI and pediatric radiology. The images
were randomly distributed, with the analy-
sis of sequences of a same patient being
performed in different days. Sites of pos-
sible involvement by lymphoma were es-
tablished, four of such locations being
nodal (neck, chest, abdomen and pelvis)
and eight extranodal (lung, chest wall, liver,
spleen, pancreas, intestinal loops and bone
marrow). The sites were classified as posi-
tive in cases where the lymph nodes were
> 1.0 cm on their smallest axes or in the
presence of signal alterations (hypo/
isosignal on T1-weighted and T2-weighted
sequences and hypersignal intensity on
STIR or DWIBS sequences) and/or masses.
The number and localization of in-
volved sites as well as the staging of each
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one of them were compared among the dif-
ferent sequences.
The following statistical analyses were
made:
– interobserver agreement on results in
relation to lymph node chains;
– interobserver agreement on results in
relation to parenchymal organs;
– interobserver agreement on results in
relation to bone marrow;
– interobserver agreement on results of
the four sequences, to find which one iden-
tifies the highest number of lesions result-
ing from the lymphoma.
RESULTS
All the images were technically appro-
priate, and no technique-related complica-
tion was observed. All the images pre-
sented a good quality, despite the presence
of artifacts which did not negatively affect
the diagnosis. Such artifacts occurred pre-
dominantly in the chest and abdomen, and
were caused by breathing, heartbeats and/
or body motion (Figure 1).
The fastest sequences were the T1- and
T2-weighted ones, taking four minutes and
16 seconds to be acquired. The STIR se-
quences took longer, seven minutes and
four seconds. The DWIBS took the long-
est time to be acquires, 12 minutes and 52
seconds.
The time required by each observer to
evaluate the images was measured. The
longest a time was observed in the analy-
sis of the DWIBS sequences, with a mean
time of 133 seconds for the observer 1 and
140 seconds for the observer 2. The other
sequences presented similar results, with a
mean required time ranging from 109 to
116 seconds.
The number of lymph node sites char-
acterized as affected by the disease on T1-
and T2-weighted sequences was similar (8
sites for both sequences), however it was
lower than the numbers observed on STIR
and DWIBS sequences (11 and 12 sites,
respectively). The difference between these
methods was due to an axillary lymph node
interpreted as affected by the disease when
visualized at the DWIBS sequence, and
that was not identified at the STIR se-
quence (Figure 2), requiring further evalu-
ation by ultrasonography, which identified
an axillary lymph node with increased di-
mensions, associated with loss of habitual
morphology and hyper vascular flow at
Doppler.
In the analysis of involvement of paren-
chymal organs, all the sequences presented
similar results. As regards bone marrow
involvement by lymphoma, the same num-
ber of lesions (17) was observed on T1-,
T2-weighted, and DWIBS sequences, su-
perior to the number of lesions (13) ob-
served on STIR sequences.
In some cases, hypersignal intensity was
identified on the DWIBS sequence, classi-
fied as non representative. In one patient,
hypersignal intensity secondary to biopsy
was observed on the right iliac crest (Fig-
ure 3). In two patients, moderate and dif-
fuse hypersignal intensity was visualized in
the bone marrow (Figure 4). In all the cases
the spleen presented hypersignal intensity
(Figure 4), a typical finding due to the or-
gan vascularization(18,20).
After the analysis of the images, the pa-
tients were staged at each sequence, ac-
cording to the Ann Arbor criteria. No dif-
ferences were detected in the staging per-
formed by the two observers, but diver-
gence was observed in two cases as regards
Figure 1. Heartbeat (A) and respiratory artifacts (B), that did not impair the detection of pulmonary nodules.
A B
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staging, i.e., higher stages (stages II and III)
were observed on STIR and DWIBS se-
quences as compared with the T1- and T2-
weighets sequences (stage I).
The kappa test was utilized in the analy-
sis of the interobserver agreement, consid-
ering a significance level corresponding to
5%. In the comparison of the results ob-
tained by the two observers in the interpre-
tation of the STIR images, a very high de-
gree of interobserver agreement was ob-
served (kappa index ranging from 0.816 to
1). Similar results were observed in the
analysis of the T2-weighted sequences,
with the kappa index ranging from 0.80 to
1. As regards the DWIBS sequence,
interobserver agreement was observed (p <
0.05), although not at the same level as the
previous methods (kappa index ranging
from 0.571 to 1). The interobserver agree-
ment was similar on the T1-weighted and
DWIBS sequences (kappa index ranging
from 0.625 to 1).
DISCUSSION
There are various potential advantages
of whole-body MRI as compared with con-
ventional imaging methods in the staging
of Hodgkin’s lymphoma. Considering that
the exposure to ionizing radiation, even at
small doses, may increase the risk for sec-
ondary neoplasias in children(21–23), whole-
body MRI, by not relying on ionizing ra-
diation, might be utilized as an alternative
imaging method in the staging of lympho-
mas. Additionally, there is no need for ei-
ther oral or intravenous administration of
contrast agents, and the evaluation of the
disease extent seems to be feasible with the
utilization of a single imaging method, re-
sulting in costs reduction, besides reduc-
tion in the need for sedation and in the
number of visits of the patient to the imag-
ing center.
The whole-body MRI feasibility has
been demonstrated in a number of dis-
eases(24–28). Some studies with adult pa-
tients with lymphoma have evaluated the
utilization of MRI, with CT as a reference
standard. By using such comparison,
Brennan et al.(29) have reported that the
STIR sequence could be used with accu-
racy in the identification of lymph nodes
> 1.2 cm.
In the follow-up and staging of lympho-
mas, whole-body MRI allows the detection
of involvement of bone marrow, lymph
nodes and parenchymal organs by this dis-
ease. Because of the potentiality of the
method, the authors decided to compare
four whole-body MRI sequences (T1-
weighted, T2-weightes, STIR and DWIBS),
evaluating the time required for the images
acquisition, images quality, identification
of the lesions, interobserver agreement and
mean analysis time for each sequence.
The shorter time for interpretation of
T1-weighted, T2-weighted and STIR im-
ages was attributed to the greater spatial
resolution of such sequences. The STIR
sequence presented higher interobserver
Figure 2. A: Axillary lymph node at right (arrow) visualized on the DWIBS sequence, which were not identified on the STIR sequence (B).
A B
Figure 3. Hypersignal intensity secondary to biopsy at the right iliac crest (arrow).
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agreement because of the greater contrast
resolution between the lesions and the ad-
jacent healthy tissue.
The two patients who presented diffuse
moderate hypersignal intensity on the bone
marrow were utilizing Granulokyne® at the
time of the images acquisition. Maybe, the
utilization of such medication have been
the cause for the hypersignal intensity, as
in the follow-up no sign of involvement of
such regions by lymphoma was observed.
Although studies in the literature report
the higher sensitivity of diffusion-weighted
MRI in the staging of metastases, as well
as in the monitoring of the response to che-
motherapy in some cases, significant dif-
ferences were not observed in the present
study with respect to the STIR sequence.
The present study faced some limita-
tions, such as the small size of the sample
and the impossibility of histological con-
firmation of the abnormalities character-
ized at MRI.
At MRI, alteration of the signal inten-
sity and/or lesion size is utilized as diagnos-
tic criterion for the presence of tumor ac-
tivity. On the other hand, PET-CT evaluates
the tumor metabolism based on the increase
in the glycolytic activity. As both diagnos-
tic methods are utilized in the staging and
follow-up of oncologic patients, the con-
tinuation of the present study shall be un-
dertaken with the correlation of whole-
body MRI with PET-CT images.
CONCLUSIONS
In the analysis of lymph node sites char-
acterized as affected by the disease, the
STIR and DWIBS sequences detected a
higher number of lesions. All the sequences
presented similar results in the evaluation
of parenchymal organs and bone marrow.
The interobserver agreement was high for
all the analyzed sequences, with the best
results being observed at the STIR se-
quence.
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